Concepedia

Maryam Ahmadi

MA

Statistics

Publications

10

Citations

622

H-Index

10

Active since

2008

Affiliations

University College London(Current)

The Royal Free Hospital

Centre for Human Drug Research

University of Bradford

University of Bristol

Maryam Ahmadi is an author at University College London specializing in immunology, cd8 positive t cells, and cancer immunology.

ORCID

Publications per year

2008–2023

10

Publications

10

Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics

Maryam Ahmadi, Christine Bryson, Edward A. Cloake et al. · Pharmaceutical Research · 2014 · 171 citations

, , +17

CD3 limits the efficacy of TCR gene therapy in vivo

Maryam Ahmadi, Judith King, Shao‐An Xue et al. · Blood · 2011 · 116 citations · Full text

, , +12

Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells<i>In vivo</i>

Maryam Ahmadi, David C. Emery, David J. Morgan · Cancer Research · 2008 · 98 citations · Full text

, , +17

IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses

Fatemah Basingab, Maryam Ahmadi, David J. Morgan · Cancer Immunology Research · 2016 · 53 citations · Full text

, , +17

Redirection to the bone marrow improves T cell persistence and antitumor functions

Anjum Khan, Ben Carpenter, Pedro Santos e Sousa et al. · Journal of Clinical Investigation · 2018 · 53 citations · Full text

, , +17

1–5 of 10